Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Pommier

Showing results (191-200 of 251) with videos related to

Pageof 26
Sort By:
Pharmaceutical Research|December 1, 1996
Application of the electrotopological state index to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitorsJ K Buolamwini, K Raghavan, M R Fesen, et al.
The Journal of Biological Chemistry|March 21, 1997
Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase IP Pourquier, L M Ueng, G Kohlhagen, et al.
Molecular Pharmacology|August 4, 1998
Highly potent synthetic polyamides, bisdistamycins, and lexitropsins as inhibitors of human immunodeficiency virus type 1 integraseN Neamati, A Mazumder, S Sunder, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 25, 2005
Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activityR Di Santo, R Costi, M Artico, et al.
Oncogene|April 21, 2001
Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cellsR G Shao, C X Cao, W Nieves-Neira, et al.
Antiviral Chemistry & Chemotherapy|December 29, 1998
Identification of HIV-1 integrase inhibitors based on a four-point pharmacophoreH Hong, N Neamati, H E Winslow, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2001
Human mitochondrial topoisomerase IH Zhang, J M Barceló, B Lee, et al.
Cancer Communications|August 1, 1991
S-phase population analysis does not correlate with the cytotoxicity of camptothecin and 10,11-methylenedioxycamptothecin in human colon carcinoma HT-29 cellsP M O'Connor, W Nieves-Neira, D Kerrigan, et al.
Molecular Pharmacology|April 1, 1996
Effects of nucleotide analogues on human immunodeficiency virus type 1 integraseA Mazumder, N Neamati, J P Sommadossi, et al.
Cancer Research|February 24, 2001
Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanineP Pourquier, J L Waltman, Y Urasaki, et al.
Pageof 26

Showing results (191-200 of 251) with videos related to

Sort By:
Pageof 26
Pharmaceutical Research|December 1, 1996
Application of the electrotopological state index to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitorsJ K Buolamwini, K Raghavan, M R Fesen, et al.
The Journal of Biological Chemistry|March 21, 1997
Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase IP Pourquier, L M Ueng, G Kohlhagen, et al.
Molecular Pharmacology|August 4, 1998
Highly potent synthetic polyamides, bisdistamycins, and lexitropsins as inhibitors of human immunodeficiency virus type 1 integraseN Neamati, A Mazumder, S Sunder, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 25, 2005
Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activityR Di Santo, R Costi, M Artico, et al.
Oncogene|April 21, 2001
Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cellsR G Shao, C X Cao, W Nieves-Neira, et al.
Antiviral Chemistry & Chemotherapy|December 29, 1998
Identification of HIV-1 integrase inhibitors based on a four-point pharmacophoreH Hong, N Neamati, H E Winslow, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2001
Human mitochondrial topoisomerase IH Zhang, J M Barceló, B Lee, et al.
Cancer Communications|August 1, 1991
S-phase population analysis does not correlate with the cytotoxicity of camptothecin and 10,11-methylenedioxycamptothecin in human colon carcinoma HT-29 cellsP M O'Connor, W Nieves-Neira, D Kerrigan, et al.
Molecular Pharmacology|April 1, 1996
Effects of nucleotide analogues on human immunodeficiency virus type 1 integraseA Mazumder, N Neamati, J P Sommadossi, et al.
Cancer Research|February 24, 2001
Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanineP Pourquier, J L Waltman, Y Urasaki, et al.
Pageof 26